Marketscreener, stock market website
1b1fcd62b2099352e41328484b.OY_Uk5UX54tTFfiaSILLYpmLbHT83ylpoBA3KTFnHJU.as2sorh9uMESSszvfbCCWuP8GACF6GUb03pkX0IWWP1xt4b5_iOVumZUiw

Log In

Forgot your password ?
Or log in with
GoogleGoogle

Email Registration
Or log in with
GoogleGoogle
Log In

Forgot your password ?
Not a member ?
Email Registration
Or log in with
GoogleGoogle
  • Markets
    Equities
    Top Capitalization
    United States
    North America
    Europe
    Asia
    Middle East
    Sector Research
    Company calendar
    Equities Analysis
    Most popular
    TESLA, INC.
    AMD (ADVANCED MICRO DEVICES)
    APPLE INC.
    NVIDIA CORPORATION
    MICROSOFT CORPORATION
    CORE SCIENTIFIC, INC.
    EXXON MOBIL CORPORATION
    Indices
    Homepage
    Rankings
    Europe
    America
    Asia
    Africa
    Index Analysis
    Indexes News
    S&P 500
    DOW JONES
    NASDAQ 100
    TSX COMP
    FTSE 100
    DAX
    CAC 40
    EURO STOXX 50
    Currency / Forex
    Homepage
    Rankings
    Currency Cross Rate
    Currency Converter
    Forex Analysis
    Currencies News
    USD / EUR
    USD / CAD
    USD / MXN
    USD / BRL
    USD / INR
    Commodities
    Homepage
    Energy
    Precious metals
    Agriculture
    Industrial Metals
    Livestock and Cattle
    GOLD
    CRUDE OIL (WTI)
    CRUDE OIL (BRENT)
    SILVER
    PLATINUM
    Cryptocurrencies
    Homepage
    Rankings
    Charts
    Analysis
    News
    Logo Crypto <span class='ml-5 txt-link txt-s1'>BITCOINBITCOIN
    Logo Crypto <span class='ml-5 txt-link txt-s1'>ETHEREUMETHEREUM
    Logo Crypto <span class='ml-5 txt-link txt-s1'>BINANCE COINBINANCE COIN
    Logo Crypto <span class='ml-5 txt-link txt-s1'>SOLANASOLANA
    Logo Crypto <span class='ml-5 txt-link txt-s1'>CARDANOCARDANO
    Logo Crypto <span class='ml-5 txt-link txt-s1'>CHAINLINKCHAINLINK
    Interest Rates
    Homepage
    Yield Curve
    Developed Nations
    Emerging Countries
    ETF
    Summary
    Screener
    Analysis
    News
  • News
    All News
    World
    United States
    Europe
    North America
    South America
    Asia
    Africa
    Middle East
    Emerging
    Companies
    All News
    Analyst Reco.
    Rumors
    IPOs
    Capital Markets Transactions
    New Contracts
    Profit Warnings
    Appointments
    Press Releases
    Security Transactions
    Earnings reports
    New markets
    New products
    Corporate strategies
    Legal risks
    Share buybacks
    Mergers and acquisitions
    Call Transcripts
    Guidance
    Indices
    Currency / Forex
    Commodities
    Cryptocurrencies
    ETF
    Interest Rates
    Economy
    Themes
    Asset Management
    Activism
    Climate and ESG
    Cybersecurity
    Geopolitics
    Central Banks
    Inflation
    Business Leaders
    Sectors
    Calendar
    Economic Calendar
    Company calendar
    All our articles
    Most Read News
    Hot News
  • Analysis
    All Analysis
    Must Read
    Equities
    Interviews
    Indices
    Currencies
    Commodities
    ETF
    Cryptocurrencies
    Stock Trading Strategies
    All
    America
    Europe
    Asia
  • Our Shows
    Shows
    Must Watch
    Satirical Cartoon
    Today's Editorial
    Crypto Recap
  • Stock Picks
    All our investments
    United States
    Europe
    Asia, Pacific
  • Portfolios
    Virtual Portfolios
    USA Portfolio
    European Portfolio
    Asian Portfolio
  • Watchlists
    My Watchlists
    Watchlists
    My previous session
    My most visited
    Most popular
    Investment Style
    Homepage
    Trend-Following Stocks
    Momentum stocks
    Quality stocks at a reasonable price
    Growth stocks at reasonable prices
    Dividend Kings
    Dividend Aristocrats
    Investment Themes
    Homepage
    Boats
    US Basketball
    The Golden Age of Video Games
    REITS
    Beauty
    Oligopolies
  • Rankings
    Top Movers
    Short-Term Gainers & Losers
    Long-term Gainers & Losers
    Unusual volumes
    New Historical Highs
    New Historical Lows
    Top Fundamentals
    Fundamental Composite
    Sales growth
    Earnings Growth
    Profitability
    Finances
    Rankings Valuation
    Valuation Composite
    Capitalization
    P/E ratio
    Enterprise value
    Yield
    Price to Book (PBR)
    Free Cash Flow (FCF)
    Top Consensus
    Consensus composite
    Analyst Opinion
    Target price
    Opinion Divergences
    Estimates Revisions
    Analyst coverage
    Technical Analysis Rankings
    RSI
    GAPS
    STIM
    Daily Breakouts
    Weekly Breakouts
    Trends
    Volatility
    Top ranking ESG
    ESG MSCI
    Environment
    Social
    Governance
    Islamic Finance
    Paris Agreement
  • Screeners
    Stock Screener Home
    Investment Themes
    Outdoor
    Hydrogen
    Warren Buffett
    Israeli innovation
    E-Commerce & Logistics
    The Vegan Market
    Technical Rankings
    Oversold stocks
    Overbought stocks
    Close to resistance
    Close to support
    Accumulation Phases
    Most volatile stocks
    Fundamental Rankings
    Top Investor Rating
    Top Trading Rating
    Top Consensus
    Top Growth
    Top Dividends
    Low valuations
    My Screeners
    All my stocks
    Watchlists
    Virtual Portfolios
  • Tools
    MarketScreener tools
    Stock Screener
    iPhone app
    Expert tools
    Stock Screener PRO
    Portfolio Creator
    Event Screener
    Dynamic Chart
    Company calendar
    Economic Calendar
    Currency Converter
  • Our Services
    Our subscriptions
    Our Stock Picks
    Stock Screener
    Thematic Investment Lists
    MarketScreener Portfolios
    European Portfolio
    USA Portfolio
    Asian Portfolio
  • Homepage
  • Markets
    • Equities
      • Top Capitalization
      • United States
      • North America
      • Europe
      • Asia
      • Middle East
      • Sector Research
      • Company calendar
      • Equities Analysis
      • Most popular
      • TESLA, INC.
      • AMD (ADVANCED MICRO DEVICES)
      • APPLE INC.
      • NVIDIA CORPORATION
      • MICROSOFT CORPORATION
      • CORE SCIENTIFIC, INC.
      • EXXON MOBIL CORPORATION
    • Indices
      • Homepage
      • Rankings
      • Europe
      • America
      • Asia
      • Africa
      • Index Analysis
      • Indexes News
      • S&P 500
      • DOW JONES
      • NASDAQ 100
      • TSX COMP
      • FTSE 100
      • DAX
      • CAC 40
      • EURO STOXX 50
    • Currency / Forex
      • Homepage
      • Rankings
      • Currency Cross Rate
      • Currency Converter
      • Forex Analysis
      • Currencies News
      • USD / EUR
      • USD / CAD
      • USD / MXN
      • USD / BRL
      • USD / INR
    • Commodities
      • Homepage
      • Energy
      • Precious metals
      • Agriculture
      • Industrial Metals
      • Livestock and Cattle
      • GOLD
      • CRUDE OIL (WTI)
      • CRUDE OIL (BRENT)
      • SILVER
      • PLATINUM
    • Cryptocurrencies
      • Homepage
      • Rankings
      • Charts
      • Analysis
      • News
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>BITCOINBITCOIN
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>ETHEREUMETHEREUM
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>BINANCE COINBINANCE COIN
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>SOLANASOLANA
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>CARDANOCARDANO
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>CHAINLINKCHAINLINK
    • Interest Rates
      • Homepage
      • Yield Curve
      • Developed Nations
      • Emerging Countries
    • ETF
      • Summary
      • Screener
      • Analysis
      • News
  • News
    • All News
      • World
      • United States
      • Europe
      • North America
      • South America
      • Asia
      • Africa
      • Middle East
      • Emerging
    • Companies
      • All News
      • Analyst Reco.
      • Rumors
      • IPOs
      • Capital Markets Transactions
      • New Contracts
      • Profit Warnings
      • Appointments
      • Press Releases
      • Security Transactions
      • Earnings reports
      • New markets
      • New products
      • Corporate strategies
      • Legal risks
      • Share buybacks
      • Mergers and acquisitions
      • Call Transcripts
      • Guidance
    • Indices
    • Currency / Forex
    • Commodities
    • Cryptocurrencies
    • ETF
    • Interest Rates
    • Economy
    • Themes
      • Asset Management
      • Activism
      • Climate and ESG
      • Cybersecurity
      • Geopolitics
      • Central Banks
      • Inflation
      • Business Leaders
    • Sectors
    • Calendar
      • Economic Calendar
      • Company calendar
    • All our articles
    • Most Read News
    • Hot News
  • Analysis
    • All Analysis
    • Must Read
    • Equities
    • Interviews
    • Indices
    • Currencies
    • Commodities
    • ETF
    • Cryptocurrencies
    • Stock Trading Strategies
      • All
      • America
      • Europe
      • Asia
  • Our Shows
    • Shows
    • Must Watch
    • Satirical Cartoon
    • Today's Editorial
    • Crypto Recap
  • Stock Picks
    • All our investments
    • United States
    • Europe
    • Asia, Pacific
  • Portfolios
    • Virtual Portfolios
    • USA Portfolio
    • European Portfolio
    • Asian Portfolio
  • Watchlists
    • My Watchlists
      • Watchlists
      • My previous session
      • My most visited
      • Most popular
    • Investment Style
      • Homepage
      • Trend-Following Stocks
      • Momentum stocks
      • Quality stocks at a reasonable price
      • Growth stocks at reasonable prices
      • Dividend Kings
      • Dividend Aristocrats
    • Investment Themes
      • Homepage
      • Boats
      • US Basketball
      • The Golden Age of Video Games
      • REITS
      • Beauty
      • Oligopolies
  • Rankings
    • Top Movers
      • Short-Term Gainers & Losers
      • Long-term Gainers & Losers
      • Unusual volumes
      • New Historical Highs
      • New Historical Lows
    • Top Fundamentals
      • Fundamental Composite
      • Sales growth
      • Earnings Growth
      • Profitability
      • Finances
    • Rankings Valuation
      • Valuation Composite
      • Capitalization
      • P/E ratio
      • Enterprise value
      • Yield
      • Price to Book (PBR)
      • Free Cash Flow (FCF)
    • Top Consensus
      • Consensus composite
      • Analyst Opinion
      • Target price
      • Opinion Divergences
      • Estimates Revisions
      • Analyst coverage
    • Technical Analysis Rankings
      • RSI
      • GAPS
      • STIM
      • Daily Breakouts
      • Weekly Breakouts
      • Trends
      • Volatility
    • Top ranking ESG
      • ESG MSCI
      • Environment
      • Social
      • Governance
      • Islamic Finance
      • Paris Agreement
  • Screeners
    • Stock Screener Home
    • Investment Themes
      • Outdoor
      • Hydrogen
      • Warren Buffett
      • Israeli innovation
      • E-Commerce & Logistics
      • The Vegan Market
    • Technical Rankings
      • Oversold stocks
      • Overbought stocks
      • Close to resistance
      • Close to support
      • Accumulation Phases
      • Most volatile stocks
    • Fundamental Rankings
      • Top Investor Rating
      • Top Trading Rating
      • Top Consensus
      • Top Growth
      • Top Dividends
      • Low valuations
    • My Screeners
      • All my stocks
      • Watchlists
      • Virtual Portfolios
  • Tools
    • MarketScreener tools
      • Stock Screener
      • iPhone app
    • Expert tools
      • Stock Screener PRO
      • Portfolio Creator
      • Event Screener
    • Dynamic Chart
    • Company calendar
    • Economic Calendar
    • Currency Converter
  • Our Services
    • Our subscriptions
    • Our Stock Picks
    • Stock Screener
    • Thematic Investment Lists
    • MarketScreener Portfolios
      • European Portfolio
      • USA Portfolio
      • Asian Portfolio
Stock NUVBNUVATION BIO INC.
Add to a list
To use this feature you must be a member
Log inSign up

Nuvation Bio Inc.

Equities

NUVB

US67080N1019

Biotechnology & Medical Research

Delayed Nyse
Other stock markets
03:59:49 2025-07-10 pm EDT
5-day change 1st Jan Change
2.305 USD -2.74% Intraday chart for Nuvation Bio Inc. +10.77% -12.97%
Jun. 30 Nuvation Bio Inc.(NYSE:NUVB) added to Russell 3000 Growth Index CI
Jun. 30 Nuvation Bio Inc.(NYSE:NUVB) added to Russell Small Cap Comp Growth Index CI
Summary
Quotes
Charts
Technical Analysis Static Chart News Chart Sector Chart Comparison Chart Relative Strength Chart
News
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
Company
Profile Governance Share ownership Connections
Financials
Analysts' Forecasts Income Statement Balance Sheet Cash flow Financial Ratios Business Segments
Valuation
Valuation ratios Dividend
Consensus
Analysts' Opinion Estimates Revisions
Calendar
Sector
Sector performance Sector valuations Sector dividends Financial comparisons Sector consensus Sector revisions
ETFs
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

US FDA approves Nuvation Bio's rare lung cancer drug

Published on 06/11/2025 at 13:34, updated on 06/11/2025 at 14:44

Share
LockThis article is reserved for members
Unlock the article: REGISTER NOW!
100% Free Registration
Already a customer? Log In
Share
Reuters logo
© Reuters - 2025

Latest news about Nuvation Bio Inc.

Nuvation Bio Inc.(NYSE:NUVB) added to Russell 3000 Growth Index Jun. 30 CI
Nuvation Bio Inc.(NYSE:NUVB) added to Russell Small Cap Comp Growth Index Jun. 30 CI
Nuvation Bio Inc.(NYSE:NUVB) added to Russell Microcap Growth Index Jun. 30 CI
Nuvation Bio Inc.(NYSE:NUVB) added to Russell 3000E Growth Index Jun. 30 CI
Nuvation Bio Inc.(NYSE:NUVB) added to Russell 2500 Growth Index Jun. 30 CI
Nuvation Bio Inc.(NYSE:NUVB) added to Russell 2000 Growth Index Jun. 29 CI
Nuvation Bio Inc.(NYSE:NUVB) added to Russell 2500 Growth Benchmark Jun. 29 CI
Nuvation Bio Inc.(NYSE:NUVB) added to Russell 3000 Growth Benchmark Jun. 29 CI
Nuvation Bio Inc.(NYSE:NUVB) added to Russell Small Cap Comp Growth Benchmark Jun. 29 CI
Nuvation Bio Inc.(NYSE:NUVB) added to Russell 3000E Growth Benchmark Jun. 29 CI
Nuvation Bio Inc.(NYSE:NUVB) added to Russell Microcap Growth Benchmark Index Jun. 29 CI
Nuvation Bio Inc.(NYSE:NUVB) added to Russell 2000 Growth Benchmark Jun. 29 CI
Sector Update: Health Care Stocks Edge Higher Premarket Tuesday Jun. 24 MT
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Tuesday Ahead of Powell Testimony Jun. 24 MT
Nuvation Bio Inc. Announces National Comprehensive Cancer Network Adds Taletrectinib as Preferred Option to Clinical Practice Guidelines in Oncology for Advanced ROS1+ Non-Small Cell Lung Cancers Jun. 24 CI
Nuvation Bio Says Taletrectinib Added as Preferred Agent in National Comprehensive Cancer Network for Lung Cancer Jun. 24 MT
RBC Cuts Price Target on Nuvation Bio to $6 From $10, Keeps Outperform, Speculative Risk Jun. 17 MT
Onco360 Has Been Selected as a National Specialty Pharmacy Partner for IBTROZI?? (Taletrectinib), Manufactured by Nuvation Bio Inc Jun. 16 CI
US FDA approves Nuvation Bio's rare lung cancer drug Jun. 11 RE
Nuvation Bio Wins US FDA Approval for Non-Small Cell Lung Cancer Drug Ibtrozi Jun. 11 MT
U.S. Food and Drug Administration Approves Nuvation Bio?s IBTROZI? (taletrectinib), a Next-Generation Oral Treatment for Advanced ROS1-Positive Non-Small Cell Lung Cancer Jun. 11 CI
US FDA approves Nuvation Bio's lung cancer therapy Jun. 11 RE
Nuvation Bio Stock Trading Halted, Pending Material News Release Jun. 11 MT
FDA Approves Taletrectinib For ROS1-Positive Non-Small Cell Lung Cancer Jun. 11 RE
Nuvation Bio Inc. Ratifies the Appointment of KPMG LLP as Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2025 May. 23 CI

Chart Nuvation Bio Inc.

Chart Nuvation Bio Inc.
NUVB: Dynamic Chart

Company Profile

Logo Nuvation Bio Inc.
Nuvation Bio Inc. is a biopharmaceutical company. The Company is engaged in tackling the unmet needs in oncology by developing differentiated and therapeutic candidates. The Company is advancing multiple clinical-stage candidates, including a ROS1 inhibitor, a mutant isocitrate dehydrogenase 1 (mIDH1) inhibitor, a bromodomain and extra-terminal (BET) inhibitor, and a drug-drug conjugate (DDC). Its portfolio of development candidates includes taletrectinib (ROS1), safusidenib (mIDH1), NUV-868 (BET), and NUV-1511 (DDC). Taletrectinib is an oral, potent, CNS-active, selective, ROS1 inhibitor specifically designed for the potential treatment of ROS1-positive non-small cell lung cancer (NSCLC). Safusidenib is an oral, potent, targeted inhibitor of mIDH1 being evaluated in a global Phase II trial in patients with low-grade IDH1-mutant glioma. NUV-868 is a BD2-selective oral small molecule BET inhibitor, that inhibits BRD4. It is conducting Phase I/II study of NUV-1511.
Employees
273
Sector
Biotechnology & Medical Research
Calendar
Aug. 05 - Q2 2025 Earnings Release (Projected)
More about the company

Income Statement and Estimates

More financial data

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
2.370USD
Average target price
7.167USD
Spread / Average Target
+202.39%
Consensus
EPS Estimates
Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar
Indices Europe America Asia
More Indexes
My Watchlist
 

My lists
Rankings
 

More Top / Flop
Rankings
 

More Top / Flop

Currency / Forex

Forex

Commodities

Commodities

Cryptocurrencies

Cryptocurrencies
  1. Stock Market
  2. Equities
  3. NUVB Stock
  4. News Nuvation Bio Inc.
  5. US FDA approves Nuvation Bio's rare lung cancer drug
Best financial portal

Best financial
portal

+951% of historicalperformance

+951% of historical
performance

More than 20 yearsat your side

More than 20 years
at your side

Trustpilot
+ 1,000,000members

+ 1,000,000
members

Quick & easycancellation

Quick & easy
cancellation

Our Expertsare here for you

Our Experts
are here for you

Download from Apple Store

OUR EXPERTS ARE HERE FOR YOU

Monday - Friday 9am-12pm / 2pm-6pm GMT + 1

Contact us
MarketScreener, Stock Market Live
Legal information | Cookie settings | MarketScreener Blog | About us | Copyright © 2025 Surperformance SAS. All rights reserved.
Stock quotes are provided by Factset, Morningstar and S&P Capital IQ
All our actual portfolios continue to outperform their benchmark.
Discover our performance
Discover our performance

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States
United-States
Canada
Canada

MIDDLE EAST

Saudi Arabia
Saudi Arabia
United Arab Emirates
United Arab Emirates

EUROPE

France
France
Deutschland
Deutschland
Suisse
Suisse
Schweiz
Schweiz
Italia
Italia
Österreich
Österreich
België
België
Nederland
Nederland
España
España
Sverige
Sverige
United Kingdom
United Kingdom

APAC

Australia
Australia
India
India
Hong Kong
Hong Kong